Meta Pixel

News and Announcements

Ideapod Capital Raise Closing Soon

  • Published July 27, 2017 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Ideapod is an innovative communication platform helping people to learn and connect around ideas. We are experiencing rapid growth, with over 2.2 million monthly active users (up from 450,000 in April) and increasing our revenue each month.

  • Ideapod is a global communication platform helping people to learn and connect around ideas;
  • The company has almost fully allocated a convertible note, raising US$ 1.5 million with US$ 9 million cap and/or 20% discount converting to preferred shares at series A (targeting valuation of $20-30 million). The company is cash flow positive;
  • The platform is experiencing rapid growth, reaching 3.6 million monthly active users (up from 450,000 in April);
  • Current investors include 37 Angels, Dragon Tree Capital, Andy Tobias (treasurer of the Democratic National Party) and Dr. Alan Dupont.

Request Offer

Capital Insights
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be  Attracting Big Pharma’s Attention

Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Join over 45,000+ sophisticated investors

Join Now